189 related articles for article (PubMed ID: 16296776)
21. [A novel pulmonary delivery system--dry powder inhalers].
Tang Y; Zhu JB; Chen XJ
Yao Xue Xue Bao; 2009 Jun; 44(6):571-4. PubMed ID: 19806884
[TBL] [Abstract][Full Text] [Related]
22. The ideal inhaler for asthma therapy.
Buck H
Med Device Technol; 2001 Sep; 12(7):24-7. PubMed ID: 12938556
[TBL] [Abstract][Full Text] [Related]
23. Aerosol device selection: evidence to practice.
Fink JB
Respir Care; 2000 Jul; 45(7):874-85. PubMed ID: 10926386
[TBL] [Abstract][Full Text] [Related]
24. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
Telko MJ; Kujanpää J; Hickey AJ
Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
[TBL] [Abstract][Full Text] [Related]
25. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model.
Sinha B; Mukherjee B
Drug Dev Ind Pharm; 2012 Feb; 38(2):171-9. PubMed ID: 21721851
[TBL] [Abstract][Full Text] [Related]
26. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size.
Coates MS; Chan HK; Fletcher DF; Raper JA
J Pharm Sci; 2006 Jun; 95(6):1382-92. PubMed ID: 16625656
[TBL] [Abstract][Full Text] [Related]
27. Aerosol delivery through an artificial airway.
MacIntyre NR
Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743
[TBL] [Abstract][Full Text] [Related]
28. Latest advances in nasal drug-delivery technology.
Bommer R
Med Device Technol; 1999 May; 10(4):22-8. PubMed ID: 10539106
[TBL] [Abstract][Full Text] [Related]
29. Dry powder inhalers for optimal drug delivery.
Newman SP
Expert Opin Biol Ther; 2004 Jan; 4(1):23-33. PubMed ID: 14680466
[TBL] [Abstract][Full Text] [Related]
30. Novel alternatives to reduce powder retention in the dry powder inhaler during aerosolization.
Heng D; Lee SH; Ng WK; Chan HK; Kwek JW; Tan RB
Int J Pharm; 2013 Aug; 452(1-2):194-200. PubMed ID: 23680726
[TBL] [Abstract][Full Text] [Related]
31. The electrospray and its application to targeted drug inhalation.
Gomez A
Respir Care; 2002 Dec; 47(12):1419-31; discussion 1431-3. PubMed ID: 12467500
[TBL] [Abstract][Full Text] [Related]
32. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.
Borgström L; Asking L; Beckman O; Bondesson E; Källén A; Olsson B
J Aerosol Med; 1998; 11 Suppl 1():S59-64. PubMed ID: 10180734
[No Abstract] [Full Text] [Related]
33. Emerging inhalation aerosol devices and strategies: where are we headed?
Zhou QT; Tang P; Leung SS; Chan JG; Chan HK
Adv Drug Deliv Rev; 2014 Aug; 75():3-17. PubMed ID: 24732364
[TBL] [Abstract][Full Text] [Related]
34. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length.
Coates MS; Fletcher DF; Chan HK; Raper JA
J Pharm Sci; 2004 Nov; 93(11):2863-76. PubMed ID: 15389665
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary vaccine delivery.
Lu D; Hickey AJ
Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
[TBL] [Abstract][Full Text] [Related]
36. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
Knoch M; Keller M
Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
[TBL] [Abstract][Full Text] [Related]
37. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
38. A novel dry powder inhaler: Effect of device design on dispersion performance.
Selvam P; McNair D; Truman R; Smyth HD
Int J Pharm; 2010 Nov; 401(1-2):1-6. PubMed ID: 20699113
[TBL] [Abstract][Full Text] [Related]
39. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
40. The influence of dose on the performance of dry powder inhalation systems.
Young PM; Edge S; Traini D; Jones MD; Price R; El-Sabawi D; Urry C; Smith C
Int J Pharm; 2005 May; 296(1-2):26-33. PubMed ID: 15885452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
